We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Mixed sites/palliation
Digital Poster
Clinical
A nationwide claim database study of single-fraction palliative radiotherapy in Japan
Yutaro Koide, Japan
E25-32
Spine SBRT for Metastatic Breast Cancer: Analysis by Biologic Subtype
Boris Mueller, USA
E25-504
SBRT local control and toxicity: our experience in a tertiary care hospital
María Concepción Matienzo Barreto, Spain
E25-561
A.I. generated prediction model of response to SBRT treatment of liver lesions through clinical and radiomic features
Savino Cilla , Italy
E25-636
Results of a prospective feasibility study using diagnostic computed tomography for palliative radiotherapy (UMIN-CTR: UMIN000054721)
Takeshi Kashiwagi, Japan
E25-718
Stereotactic Body Radiotherapy (SBRT) in the Treatment of Spine Metastases: An Observational Retrospective Study in a Tertiary Cancer Centre
Miguel Ferreira, Portugal
E25-773
Multi-institutional retrospective study of treatment of liver lesions with SBRT
donatella caivano, Italy
E25-848
Predictive factors of response in lung metastases treated by SBRT from colon rectal cancer
donatella caivano, Italy
E25-849
Patterns of palliative radiotherapy use: experience of the national institute Sidi Mohammed Ben Abdellah in Rabat, Morocco
Rachida Laraichi, Morocco
E25-866
Methodology of a living systematic review: The OligoCare LINACS study
Sabrina Reichl, Switzerland
E25-1027
A prospective study on Quality of Life associated with pain response and patient classification system for palliative radiotherapy
Yutaro Koide, Japan
E25-33
CBCT-only workflow for bone metastasis, a feasibility study
Mattias Hedman, Sweden
E25-1114
Preliminary results of a CyberKnife SBRT for extracranial sites from a tertiary institute
Bhooshan Purushottam Zade, India
E25-1228
Impact of simultaneous integrated dose boost in spinal bone oligometastases SBRT : report of a mono-institutional large experience
Edoardo Pastorello, Italy
E25-1378
profilactic radiotherapy for hips and elbows heterotopic ossification: a retrospective multicentre experience
Luca Frassinelli, Italy
E25-1388
Early safety and efficacy results of a prospective dose de-escalation clinical trial of cardiac radioablation for ventricular tachycardia(NCT05258422)
Ian Gerard, Canada
E25-1394
Prognostic score for patients with spinal bone metastases after surgery – Who will benefit from postoperative radiotherapy?
Justus Kaufmann, Germany
E25-1409
PERSONAL - Personalized extended-interval fractionated SBRT using online adaptive planning: enhancing efficacy and tolerability in metastatic patients
Alessandra Castelluccia, Italy
E25-1414
A review of 130 Cyberknife spinal metastasis SABR treatments at one centre to assess risk of spinal cord toxicity
Timothy Jackson, United Kingdom
E25-1417
Contrast-Associated Acute Kidney Injury Among Oncology Patients Undergoing CT Radiotherapy Planning Scans: A Retrospective Cohort Study
Bhurint Siripanthong, United Kingdom
E25-1522
Comparative Outcomes of 0-7-21 and 20 Gy in 5 Fractions Palliative Radiotherapy Regimens for Breast Cancer: A Multicenter Study
Majd Alotaibi, Saudi Arabia
E25-1637
Linear regression model for prediction of complete blood count parameters during radiotherapy
Aniwat Berpan, USA
E25-49
LOW-DOSE RADIOTHERAPY FOR PAINFUL MUSCULOSKELETAL DISORDERS: 10 YEARS FOLLOW-UP.
Angel Montero, Spain
E25-1662
A single click for a VMAT plan – an automated tool to shorten the time to palliative radiotherapy
Julie Ahn, Australia
E25-1860
Efficacy and tolerability of single fraction radiotherapy for spinal bone metastases in a low-middle-income country setting: a prospective study.
Alessio Giuseppe Morganti, Italy
E25-1909
Reasons of discontinuation of radiotherapy during 2020-2023: a single-institution review
Javier González-Viguera, Spain
E25-1956
Preliminary experience with pain education in palliative radiotherapy for bone metastases: impact on patient satisfaction and retention.
Costanza Maria Donati, Italy
E25-2003
Clinical safety and efficacy of palliative Simultaneous Integrated Boost Lattice RT in patients with advanced cancers: A prospective analysis
Preetha Umesh, India
E25-2074
Outcome result and toxicity of Stereotactic radiotherapy in patients with brain metastases from gastrointestinal cancer
Michele Aquilano, Italy
E25-2097
Long-term local control and prognostic factors in oligometastatic disease
Silke Dirkx, Belgium
E25-2155
External beam radiotherapy for synchronous prostate and rectal cancer.
Maxim Van den Kieboom, Belgium
E25-2164
SBRT in bone metastases disease: local control and pain flare in patients treated with single-fraction versus multi-fraction schemes
María Concepción Matienzo Barreto, Spain
E25-2219
Risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery
Hidetoshi Shimizu, Japan
E25-64
Increased iso-toxic dose to the target in oligometastatic abdominal lymph nodes using CT-guided online adaptive SBRT
Lucy van Werkhoven, The Netherlands
E25-2332
Clinical and Dosimetric Insights from the First 100 Patients Treated with CBCT-based Online Adaptive Radiotherapy: A Single-Institution Evaluation
Kynann Aninditha, Germany
E25-2353
Online adaptive palliative radiotherapy on a standard linac without a dedicated planning CT – first experiences from the Rapid Care trial
Rune Thing, Denmark
E25-2414
Feasibility and acceptability of using electronic patient-reported outcome measures (ePROMs) in follow-up care after radiotherapy
Thitikorn Nuamek, United Kingdom
E25-2460
Management of Diaphragm Motion with Non-Custom Abdominal Corset and Shallow Breathing in Stereotactic Body Radiotherapy: A Single-Center Study
Meltem Kirli Bolukbas, Turkey
E25-2590
Hyperthermia and Radiotherapy Clinical Trials at Catalan Institute of Oncology: Initial Results
Javier González-Viguera, Spain
E25-2615
Prospective clinical trial using gantry-less image-guided proton therapy for locally recurrent head and neck and brain malignancies
Philip Blumenfeld, Israel
E25-2623
Gastro-intestinal toxicity: NTCP models based on CT-guided online adaptive SBRT for abdominal lymph node oligometastases
Lucy van Werkhoven, The Netherlands
E25-2718
SBRT-PATHY for Unresectable Tumors: Our Center’s Experience
Maria Borras , Spain
E25-2742
Do we need a CTV? Local failure rates and patterns after stereotactic body radiotherapy (SBRT) for non-spinal, non-sacral bone metastases.
Elisa Bodson, Belgium
E25-2818
Patient adherence to fasting during external radiotherapy for cancer treatment
Cyrine Mokrani, Tunisia
E25-87
Body composition is associated with worse clinician- and patient-reported late radiotherapy-related toxicity in the REQUITE study.
Alexander Vickers, United Kingdom
E25-2830
Stereotactic body radiotherapy without systemic therapy for oligometastatic cancer - a systematic review and meta-analysis
Camilla Isabel Sophie von Wachter, Switzerland
E25-2833
Clinical Implementation And Outcomes Of SRT/SBRT With Linac-Based VMAT Technique In A Less Resourced Country- A Single Center Experience
Md Abdul Mannan, Bangladesh
E25-2842
Trends in fractionation patterns for bone metastases: a retrospective multi-center study
Yvette van der Linden, The Netherlands
E25-2942
Multi-Institutional Analysis of MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy: Safety, Efficacy, and Feasibility
Michael Chuong, USA
E25-2970
Personalized by Single Fraction Eight-Gray Palliative SBRT For Bone M+ Pain: the SAINT Study; Single Arm Phase 2 Cohort Analysis for worst prognosis
Francesco Cellini, Italy
E25-3043
Preliminary Results of Magnetolith® Therapy for Pain Management in Gynecological Cancer Patients Post-Radiotherapy
Javier Anchuelo, Spain
E25-3045
Effectiveness and Safety of Stereotactic Body Radiotherapy for Bone Metastases: Monocentric Clinical Cohort from Czech Republic
Marek Slavik, Czech Republic
E25-3048
Personalized SBRT for bone metastases- A phase III randomized multicentric trial (PREST Trial): preliminary analysis on technical feasibility
Francesco Cellini, Italy
E25-3060
Toxicity of concurrent biological cancer therapy and stereotactic radiotherapy: a comparison of retrospective and prospective data collection
Esmee Lauren Looman, Switzerland
E25-3083
Proton beam therapy in cancer treatment: a systematic review of randomised trials
Chia Ching Lee, Singapore
E25-90
International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases: a second update
Jane Jomy, Canada
E25-3127
Reirradiation: an ideal workflow from literature to every-day clinical practice
Federico Mastroleo, Italy
E25-3291
Timely integration of palliative care into oncology care for patients with bone metastases at the radiotherapy department: a pilot study
Yvette van der Linden, The Netherlands
E25-3320
Feasibility and accuracy of simulation-free (SF-RT) versus CT simulation based (CT-RT) Radiation Therapy in routine practice for palliative radiation
Mansi Barthwal, India
E25-3330
Analysis of local control and pain relief of rib metastases treated with Stereotactic Body Radiotherapy
Chiara Mattioli, Italy
E25-3389
Malignancy of Unknown Origin service - avoiding unnecessary investigations and improving treatment times, with high patient and colleague satisfaction
Laura Jones, United Kingdom
E25-3515
Development of a predictive model for patients with bone metastases referred to palliative radiotherapy: secondary analysis (trial PRAIS)
Costanza Maria Donati, Italy
E25-3517
Use of Stereotactic Body Radiotherapy (SBRT) for Spine Metastases with Robotic Radiosurgery Unit Cyberknife in Patients with Oligometastatic Disease
Adrian Durango Mendez, Spain
E25-3732
Re-irradiation experience: Is it underused in XXI century?
Escarlata López, Spain
E25-3765
Stereotactic body radiotherapy combined with immunotherapy or targeted therapy: a screenshot from Italy
Maria Giulia Vincini, Italy
E25-3838
Partially Ablative Body Radiotherapy (PABR): A widely applicable planning technique for palliation of locally advanced unresectable tumour
Adam Yeo, Australia
E25-210
SALVAGE STEREOTACTIC REIRRADIATION FOR LOCAL RECURRENCES OF SPINAL METASTASIS
Miriam Torrisi, Italy
E25-3907
Radiotherapy for oligo-metastatic thymic tumours: an international experience.
Marco Banini, Italy
E25-3995
Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases
Arturo Navarro-Martin, Spain
E25-4035
Survival and Progression Outcomes in Vertebral Metastases: A Comparative Analysis of SBRT and EBRT
Mateo Jukic, Germany
E25-4078
Comparison of Vertebral Fracture Incidence and Pain Dynamics in EBRT vs. SBRT for Vertebral Metastases: A Retrospective Analysis
Leonie von Brunn, Germany
E25-4105
Capsaicin Patch Therapy for Chronic Neuropathic Pain in Breast Cancer Survivors: Importance of Early Diagnosis and Intervention
Javier Anchuelo, Spain
E25-4161
Reirradiation of Bone Metastases: Satisfactory Local Control with Low Toxicity in a Large Retrospective Series
Maria Giulia Vincini, Italy
E25-4201
Four years' experience of thoracic re-irradiation in a single centre.
MARIE SUNYACH, France
E25-4213
Half-body irradiation with the possibility of escalated dose under the spotlight of newer systemic therapies: the dawn of new therapeutic chances?
Valentina Zagardo, Italy
E25-4225
Internal Audit of Palliative Radiotherapy Protocols: Impact of Fractionation and 30-Day Mortality Outcomes in Advanced Cancer Patients
Alfonso Valcárcel Díaz, Spain
E25-4262
Radiotherapy as a Vital Treatment for Liver Metastases: Evidence from a 20-Year SEER Cohort
Feng Zhao, China
E25-352
Turning the pain down: Enhancing quality of life in radiation oncology inpatient department.
Jesus Romero Fernandez, Spain
E25-4301
First in Human Minibeam Radiation Therapy: A Single Institutional Case Series
Kiran Chauhan, USA
E25-4306
Re-irradiation with Proton therapy: acute toxicity and early clinical outcomes
Daniela Alterio, Italy
E25-4315
Does Nutrition Matter? Exploring It´s Impact on Quality of Life in Radiation Oncology inpatient department.
Sofia Santana Jimenez, Spain
E25-4366
Hypofractionated Re-irradiation: the new frontier for Proton Therapy
Daniela Alterio, Italy
E25-4372
Stereotactic Radiosurgery for Extracranial Oligometastatic Patients: Preliminary Results from a Prospective Observational Study
Marco Galaverni, Italy
E25-4379
Hypofractionation in Proton therapy: the European Institute of Oncology preliminary experience
Daniela Alterio, Italy
E25-4398
External validation of two scoring systems for survival prediction after SBRT for spinal metastases
Maria Waltenberger, Germany
E25-4413
Efficacy and safety of SBRT for intra-cardiac tumors and metastases: A systematic review and treatment outcome analysis
Maiwand Ahmadsei, Switzerland
E25-4431
Delineation of Supraclavicular Lymph Node Levels in Abdominopelvic Tumors: Insights from the ‘Block-Reflux’ Lymphatic Pathway—A Retrospective Study
Jielin Wei, China
E25-4444
The Japanese nationwide registry data analysis of particle beam therapy for metastatic liver cancers
Nobuyoshi Fukumitsu, Japan
E25-385
Stereotactic Body Radiotherapy as Adrenal Gland Metastasis-Directed Therapy in Oligometastatic Patients
Marco Galaverni, Italy
E25-4447
EFFICACY OF LOW-DOSE RADIOTHERAPY IN TREATING REFRACTORY LEDDERHOSE DISEASE: PRELIMINARY RESULTS
María Luisa Pérez Rodríguez, Spain
E25-4454
First patients treated with discrete Proton Arc Therapy at the Proton Therapy Centre in Trento
Marco Cianchetti, Italy
E25-4479
Dosimetric Predictors for Radiotherapy-induced Cardiotoxicity in Thoracic Cancers: A Systematic Review and Meta-analysis
Victor Aguirre Bravo, Chile
E25-4558
Radiotherapy for Managing Sialorrhea in Amyotrophic Lateral Sclerosis: A Palliative Approach for Patients with Poor Clinical Condition
Miroslava Slavikova, Slovakia
E25-4579